Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
68 hedge funds and large institutions have $365M invested in Amryt Pharma plc American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 7 closing their positions.
339% more call options, than puts
Call options by funds: $145K | Put options by funds: $33K
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
31% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 13
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
10% more funds holding
Funds holding: 62 → 68 (+6)
6% less capital invested
Capital invested by funds: $390M → $365M (-$24.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
+$37.9M |
| 2 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$11.9M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$9.67M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$3.14M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$2.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$1.78M |
| 2 |
AG
Artal Group
Luxembourg
|
-$1.63M |
| 3 |
NFGH
Nan Fung Group Holdings
Kai Tak,
Hong Kong
|
-$207K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$167K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$141K |
AMYT Hedge Fund Activity: Q1 2022 in Review
68 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q1 2022, worth a combined $365M — down 6.4% from $390M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new AMYT positions and 7 closed out — a net gain of 6 holders — while 17 added to existing stakes and 13 trimmed.
The largest buyer was Highbridge Capital Management, adding an estimated $37.9M. The largest seller was Silverarc Capital Management, cutting an estimated $1.78M.
- 68 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q1 2022, up from 62 in Q4 2021.
- Funds reported $365M of Amryt Pharma plc American Depositary Shares stock for Q1 2022, down 6.4% quarter-over-quarter.
- 13 funds opened new Amryt Pharma plc American Depositary Shares positions in Q1 2022 and 7 closed out, a net change of +6 holders.
- The largest Amryt Pharma plc American Depositary Shares buyer in Q1 2022 was Highbridge Capital Management, an estimated $37.9M added.
- The largest Amryt Pharma plc American Depositary Shares seller in Q1 2022 was Silverarc Capital Management, an estimated $1.78M sold.
Based on aggregated 13F filings for Q1 2022.